Nanovibronix, Inc. (NASDAQ:FEED) Short Interest Update

Nanovibronix, Inc. (NASDAQ:FEED) was the recipient of a significant drop in short interest during the month of August. As of August 31st, there was short interest totaling 87,719 shares, a drop of 74.5% from the August 15th total of 344,075 shares. Based on an average daily trading volume, of 212,831 shares, the short-interest ratio is presently 0.4 days. Currently, 10.8% of the company’s shares are sold short.

Insider Activity

In other Nanovibronix news, insider Christian Michael Glibert sold 17,500 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $8.28, for a total value of $144,900.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 12.20% of the company’s stock.

Wall Street Analyst Weigh In

FEED has been the subject of several recent analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of Nanovibronix in a report on Tuesday, July 21st. Wall Street Zen upgraded shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a report on Sunday, July 12th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

Nanovibronix Stock Down 6.4%

Shares of FEED stock traded down $0.23 during trading on Monday, reaching $3.35. The company’s stock had a trading volume of 21,262 shares, compared to its average volume of 419,275. Nanovibronix has a one year low of $3.33 and a one year high of $208.80. The business has a fifty day moving average price of $4.69 and a 200-day moving average price of $12.13. The company has a market cap of $3.08 million, a price-to-earnings ratio of -0.03 and a beta of 1.38.

Nanovibronix (NASDAQ:FEED) last issued its quarterly earnings results on Monday, August 17th. The company reported ($23.76) earnings per share (EPS) for the quarter. Nanovibronix had a negative net margin of 1,093.61% and a negative return on equity of 60.73%. The business had revenue of $0.24 million during the quarter.

Nanovibronix Company Profile

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.